AbstractBackgroundThe purpose of this study was to investigate with neurophysiological and neuropsychological methods such as pupillometry, cognitive test and Hamilton Depression Rating Scale (HAM-D) the hypothesis of Central Nervous System (CNS) cholinergic involvement in patients with Myasthenia Gravis (MG).MethodsThirty-two patients (32) with MG and a mean age of 51.1±17.2 volunteered to participate in this investigation, while thirty-three (33) healthy subjects with a mean age of 50.2±14.8 served as controls. All subjects underwent pupillometric measurements and performed the Wechsler Memory Scale (WMS) and HAM-D. The pupillometric indices studied were: 1) latency for the onset of constriction (T1), 2) maximum constriction velocity (VCm...
Myasthenia gravis (MG) is a neuromuscular autoimmune disease that affects the skeletal muscle throug...
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder in which disabling muscle weakness ma...
In this study we demonstrate that myasthenia gravis, an autoimmune disease strongly identified with ...
The relationship between myasthenia gravis (MG) and cognitive dysfunction has been a matter of debat...
Aim: During the past decade, there has been an increasing interest in the evaluation of cognitive fu...
There are reports of central cholinergic deficits in myasthenia gravis (MG) describing impaired perf...
Background: Antibodies against acetylcholine receptors (AChRs) can also target nicotinic AChRs that ...
At the present time, the study of cognitive impairment in patients with existing myasthenia gravis i...
This article is dedicated to the impact of dysfunction of the basal cholinergic system on the state ...
The article presents the results of a comprehensive neuropsychological examination of patients with ...
Myasthenia gravis is a chronic lesion of the peripheral neuromuscular apparatus, which leads to weak...
Objective: The studies have produced contradictory results regarding the association between myasthe...
Myasthenia gravis (MG) is an autoimmune disorder characterized by pathogenic antibodies against acet...
Research tasks: 1. To evaluate demographic parameters in patients with myasthenia gravis. 2. To eval...
The relative risk of developing depression in myasthenia gravis is 2.14 times higher than in the gen...
Myasthenia gravis (MG) is a neuromuscular autoimmune disease that affects the skeletal muscle throug...
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder in which disabling muscle weakness ma...
In this study we demonstrate that myasthenia gravis, an autoimmune disease strongly identified with ...
The relationship between myasthenia gravis (MG) and cognitive dysfunction has been a matter of debat...
Aim: During the past decade, there has been an increasing interest in the evaluation of cognitive fu...
There are reports of central cholinergic deficits in myasthenia gravis (MG) describing impaired perf...
Background: Antibodies against acetylcholine receptors (AChRs) can also target nicotinic AChRs that ...
At the present time, the study of cognitive impairment in patients with existing myasthenia gravis i...
This article is dedicated to the impact of dysfunction of the basal cholinergic system on the state ...
The article presents the results of a comprehensive neuropsychological examination of patients with ...
Myasthenia gravis is a chronic lesion of the peripheral neuromuscular apparatus, which leads to weak...
Objective: The studies have produced contradictory results regarding the association between myasthe...
Myasthenia gravis (MG) is an autoimmune disorder characterized by pathogenic antibodies against acet...
Research tasks: 1. To evaluate demographic parameters in patients with myasthenia gravis. 2. To eval...
The relative risk of developing depression in myasthenia gravis is 2.14 times higher than in the gen...
Myasthenia gravis (MG) is a neuromuscular autoimmune disease that affects the skeletal muscle throug...
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder in which disabling muscle weakness ma...
In this study we demonstrate that myasthenia gravis, an autoimmune disease strongly identified with ...